Data presented herein not only further support that mutant KIT induces motility of melanocytes and melanoma cells in vitro, but also indicate an in vivo migratory advantage of KIT mutant melanoma that might, at least in part, contribute to the field effect and high rate of local recurrence in KIT activated melanoma. The gene discussed is KIT; the disease is melanoma.